The Company recently reported a major expansion in retail distribution, with one national pharmacy chain nearly doubling the number of stores carrying GlucoDown® from approximately 1,250 locations to roughly 2,500 locations nationwide. In response to the broader retail footprint,
Management believes the combination of expanded distribution and targeted consumer marketing is contributing to increased product demand and stronger replenishment orders from retail partners. The company believes that the increase of these two factors serves to underscore increasing demand and accelerating product adoption at retail.
"Our recent results demonstrate a strong relationship between our advertising initiatives and retailer purchasing activity," said
Chris Jemapete, a Member of the Glucose Health Board of Directors, added: "This level of growth reflects consumers' increasing interest in healthier, functional beverage alternatives. We are encouraged by the positive sales trends we are seeing across two of the largest pharmacy chains in
"Even for GLP-1 users, post-meal glucose fluctuations can occur, particularly as dosages change or individuals transition off treatment," he said. "Clinical research supports the ability of GlucoDown's® soluble fiber ingredient to help moderate post-meal increases in blood glucose levels. “The functional benefits of GlucoDown® are a practical, affordable, food-friendly nutritional tool that supports the same metabolic health goals many GLP-1 users are already pursuing."
GlucoDown® offers a total of 8 great tasting flavors, providing consumers with a variety of choices that includes four “Decaffeinated Tea” flavors Peach, Lemon, Raspberry and Super Berry, as well as four “Enhanced Water” flavors consisting of
About Glucose Health, Inc. Glucose Health, Inc. (OTCID:GLUC) is a consumer health and wellness company focused on developing and marketing innovative nutritional products designed to support healthy blood sugar management and metabolic health. The Company's flagship product, GlucoDown®, is a soluble fiber-based beverage formulated to help maintain healthy blood glucose levels as part of a balanced diet and healthy lifestyle.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of federal securities laws. These statements include, but are not limited to, expectations regarding future sales growth, retail expansion, consumer demand, and market opportunities related to GLP-1 therapies. Actual results may differ materially from those projected due to various risks and uncertainties. Investors are encouraged to review the Company's public filings for additional information regarding factors that may affect future results.
This version adopts a more institutional investor-relations tone, tightens the language, improves the flow of the growth story, and presents the GLP-1 discussion in a manner that is more appropriate from a regulatory and public-company communications perspective.
Press Inquiries
Mark Schaftlein
schaftlein [at] juno.com
https://glucodown.com/
A video accompanying this announcement is available here: https://youtube.com/watch?v=ss_cZy4hXik
Source: Glucose Health Inc.
